{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/prov/338757447"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/17488119" ] } },

    { "id" : "http://webisa.webdatacommons.org/17488119"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Speedel Pharma announced positive results from phase I studies a pair of their investigational rennin inhibitors, SPP630 and SPP635, for the treatment of hypertension and protection of end-organs including the heart and kidneys." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "centerwatch.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/159316521"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/17488119" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/391746917"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/17488119" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/424911837"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/17488119"] } } }
